Shilpa Pharma Lifesciences clears Brazilian GMP test with minor observations

The inspection, conducted by Brazilian regulatory authority ANVISA, was held between June 30 and July 4. Earlier, it had cleared the EU audit. Shares of Shilpa Medicare Ltd ended at ₹901.90, up by ₹14.15, or 1.59%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *